The HCPLive gastroesophageal reflux disease page is a comprehensive resource for clinical news and insights on GERD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for reflux disease, and more.
July 18th 2024
Vonoprazan (Voquezna), the first major innovation in GERD treatment in more than 30 years, is now FDA-approved for both erosive and non-erosive GERD.
Newly Approved GERD Drug Melts in Your Mouth
The US Food and Drug Administration (FDA) has approved dexlansoprazole (Dexilant SoluTab/Takeda Pharmaceuticals), a new formulation for the treatment of heartburn-associated gastroesophageal reflux disease (GERD) in adults age 18 and older.
Barrett's Esophagus: Drugs Key to Less Resection Bleeding
Raised lesions of dysplatic Barrett's esophagus (BE) are treated with endoscopic mucosal resection (EMR) before ablation. But the procedure causes bleeding in 10% of cases.Mayo Clinic researchers said they found a way to reduce those adverse events.
New Procedure Successfully Controls Symptoms of Gastroesophageal Reflux Disease
September 17th 2015The LINX Reflux Management System was recently shown to successfully control reflux-related symptoms in patients with gastroesophageal reflux disease (GERD), reducing their need to continue treatment with proton pump inhibitors (PPIs) and other acid-suppression medications.
Genomic Testing to Help ID Esophageal Cancer Patients
Research recently published in the Journal of Molecular Diagnostics reveals a new next-generation sequencing (NGS) test to detect genomic mutations in precarious esophageal tissue – potentially improving early detection in individuals with Barrett's esophagus (BE).
Meeting the Challenges of Value Demonstration in GI Practice
"There are only 2 or 3 things I know for sure. Only 2 or 3 things. That's right. Of course, it's never the same things, and I'm never as sure as I'd like to be," nuggets of wisdom (from the novel "Bastard Out of Carolina," by Dorothy Allison) that Thomas Murray, Senior Director of Quality Measurement & Improvement, AGA, shared at the 2015 AGA Clinical Congress of Gastroenterology & Hepatology.
Transoral Fundoplication: Effective GERD Treatment?
According to a new study published in Gastroenterology, research results showed that transoral fundoplication, an incision-less procedure allowing anti-reflux valve alteration, is an effective treatment for patients afflicted with gastroesophageal reflux disease (GERD).
2014 Shows Progress in Treatment of Gastrointestinal Issues
December 31st 2014From inflammatory bowel disease to Crohn's disease and everywhere in the gastrointestinal system in between 2014 was a big year for medical breakthroughs and potential future treatments. Here is a look at the top 10 stories.
Hyperpigmented Back Lesion in a Young Woman
July 22nd 2014This 28-year-old woman presented with a large hyperpigmented patch on the right side of her upper back. Although the lesion developed over the past 2 years, it has been "sinking in" over the past 2 weeks. The patient denies any trauma, pain, discomfort, or pruritis, as well as any family history of cancers, lymphoma, or autoimmune disease. However, she has a history of gastroesophageal reflux disease and onychomycosis, and her grandfather has a similar lesion.
Cost-Effective pH Testing Can Rule Out GERD
May 20th 2013Esophageal pH monitoring is more cost effective than the long-term use of proton-pump inhibitors (PPIs), since it can help rule out gastroesophageal reflux diseases (GERD) and avoid the unneeded costs associated with prolonged medication therapy.
Tips to Avoid GERD Symptoms for Holiday Meals
December 19th 2011This holiday season, giant holiday meals will be the source of painful symptoms-such as heartburn-for the 45 million Americans living with acid reflux, including many who suffer from gastroesophageal reflux disease (GERD). Doctors across the nation, however, are striving to aid these sufferers by conveying some tips on how to avoid acid reflux issues this season.
Clinical Characteristics of Refractory GERD Patients Investigated
December 15th 2011A research group based in Israel has published results of a study investigating how the clinical characteristics of gastroesophageal reflux disease patients who respond to proton pump inhibitor therapy differ from those of patients who fail to respond.